Cargando…
Interstitial high-dose-rate brachytherapy as a boost in synchronous prostate and rectal cancer treatment: case report and literature review
PURPOSE: Prostate and colorectal cancers are the first and the third most popular malignancies in male population, in which some patients may develop these tumors metachronously or synchronously. At present, there are no standard recommendations, and oncologists need to provide an optimal management...
Autores principales: | Konat-Bąska, Katarzyna, Chicheł, Adam, Staszek-Szewczyk, Urszula, Maciejczyk, Adam, Matkowski, Rafał |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207231/ https://www.ncbi.nlm.nih.gov/pubmed/32395143 http://dx.doi.org/10.5114/jcb.2020.94585 |
Ejemplares similares
-
Does Breast Cancer Increasingly Affect Younger Women?
por: Konat-Bąska, Katarzyna, et al.
Publicado: (2020) -
Improvements in Undergraduate Oncology Education Introduced at Polish Medical Universities Between 2004 and 2010 Under Poland’s “National Program for Combating Neoplastic Diseases”
por: Matkowski, Rafał, et al.
Publicado: (2014) -
Correlation between treatment plan parameters and particular prognostic factors in prostate cancer treated with high–dose–rate brachytherapy (HDR–BT) as a boost
por: Chicheł, Adam, et al.
Publicado: (2009) -
Thermal Boost Combined with Interstitial Brachytherapy in Early Breast Cancer Conserving Therapy—Initial Group Long-Term Clinical Results and Late Toxicity
por: Chicheł, Adam, et al.
Publicado: (2022) -
Adjuvant interstitial three-dimensional pulse-dose-rate-brachytherapy for lip squamous cell carcinoma after surgical resection
por: Chyrek, Artur Jan, et al.
Publicado: (2019)